作为营养状况和炎症的生物标志物,用于预测患有癌症缓解症患者的结果:一个前性的多中心研究
Xiangrui Li1,2,3, Li Deng1,2,3, Hailun Xie1,2,3
1Department of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
BMC cancer
|March 26, 2025
概括
预后营养CRP比率 (NCR) 可以预测癌症症患者的存活率. 较高的NCR水平表明更好的预后和更好的生活质量,使其成为一个有价值的预后标记.
科学领域:
- 在瘤学瘤学.
- 临床营养学 临床营养学
- 生物统计学 生物统计学
背景情况:
- 系统性炎症和营养状况显著影响癌症缓解症预后.
- 癌症缓解症是一种复杂的多因素综合征,其特点是不自发的体重减轻和肌肉消耗.
- 有效的预后标志物对于治疗癌症缓解症患者至关重要.
研究的目的:
- 在患有癌症缓解症的患者中评估预后营养CRP比率 (NCR) 的预后价值.
- 评估该患者群体中NCR和全因死亡率之间的关联.
- 确定NCR作为癌症缓解症结果预测工具的实用性.
主要方法:
- 一项前性多中心研究,涉及中国3447名癌症缓解症患者.
- 通过公式计算NCR:BMI × 专蛋白 / CRP.
- 考克斯比例危险回归和受限制的立方线建模用于分析死亡风险.
- 最多选择的等级统计数据确定了最佳的NCR截止值.
主要成果:
- 在各种癌症类型和患者亚组中观察到较低的NCR水平,包括性别,年龄,BMI和TNM阶段的差异.
- 在较低的NCR和增加的全因死亡率之间发现了显著的相关性.
- 较高的NCR水平与癌症缓解症患者的生活质量显著改善有关.
- 作为一个预后标志物,NCR在不同人群中表现出广泛的适用性.
结论:
- 预后营养CRP比率 (NCR) 是癌症缓解症的一个有价值的预后标志物.
- 在这些患者中,NCR有效地反映了营养状况和全身炎症.
- 较高的NCR水平与降低全因死亡率和癌症缓解症患者更好的生活质量有关.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
290
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
290
Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
40
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40


